RIME Therapeutics
PrivateLast Round
Seed
Apr 30, 2026
Total Funding Raised
$100,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
RIME Therapeutics is a biotechnology company that provides a peptide-based drug discovery platform to identify protein-protein interaction targets and accelerate small molecule development for inflammation and immunology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RIME Therapeutics Comparables
Compare RIME Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oryn Therapeutics | 76% | |
| Azcuris | 65% | |
| AbbVie | 63% | |
RIME Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 30, 2026 | ||||
| Accelerator | Jul 1, 2025 |
Key People
Founding team and executive leadership
RIME Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Seed |
| Consortium Québécois sur la découverte du médicament | Accelerator, Seed |
| Merck Digital Sciences Studio | Accelerator |
| Merck Capital Ventures | Accelerator |
| Centech | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Seed round led by Amplitude Ventures.
RIME Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RIME Therapeutics's valuation, stock price, and market status.